These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2536828)

  • 1. Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein.
    Hauber J; Malim MH; Cullen BR
    J Virol; 1989 Mar; 63(3):1181-7. PubMed ID: 2536828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat.
    Garcia JA; Harrich D; Pearson L; Mitsuyasu R; Gaynor RB
    EMBO J; 1988 Oct; 7(10):3143-7. PubMed ID: 3181132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events.
    Hauber J; Perkins A; Heimer EP; Cullen BR
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6364-8. PubMed ID: 3476953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of expression of human immunodeficiency virus.
    Pavlakis GN; Felber BK
    New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication.
    Sadaie MR; Mukhopadhyaya R; Benaissa ZN; Pavlakis GN; Wong-Staal F
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1257-63. PubMed ID: 2078407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of vaccinia virus vectors to study the synthesis, intracellular localization, and action of the human immunodeficiency virus trans-activator protein.
    Falkner FG; Fuerst TR; Moss B
    Virology; 1988 Jun; 164(2):450-7. PubMed ID: 2835862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression.
    Green M; Ishino M; Loewenstein PM
    Cell; 1989 Jul; 58(1):215-23. PubMed ID: 2752420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cell lines stably expressing HIV env and tat gene products.
    Sosa MA; DeGasperi R; Fazely F; Ruprecht RM
    Biochem Biophys Res Commun; 1989 May; 161(1):305-11. PubMed ID: 2543412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from HIV: movement of macromolecules inside the cell.
    Fackler OT; Peterlin BM; Weis K
    Curr Mol Med; 2001 Mar; 1(1):1-7. PubMed ID: 11899237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
    Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
    New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional characterization of human immunodeficiency virus tat protein.
    Ruben S; Perkins A; Purcell R; Joung K; Sia R; Burghoff R; Haseltine WA; Rosen CA
    J Virol; 1989 Jan; 63(1):1-8. PubMed ID: 2535718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation.
    Elangovan B; Subramanian T; Chinnadurai G
    J Virol; 1992 Apr; 66(4):2031-6. PubMed ID: 1548750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.
    Kuppuswamy M; Subramanian T; Srinivasan A; Chinnadurai G
    Nucleic Acids Res; 1989 May; 17(9):3551-61. PubMed ID: 2542902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.
    Derse D; Newbold SH
    Virology; 1993 Jun; 194(2):530-6. PubMed ID: 8389074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional but not translational regulation of HIV-1 by the tat gene product.
    Rice AP; Mathews MB
    Nature; 1988 Apr; 332(6164):551-3. PubMed ID: 2833703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
    Song CZ; Loewenstein PM; Green M
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9357-61. PubMed ID: 7937769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations.
    Felser JM; Klimkait T; Silver J
    Virology; 1989 Jun; 170(2):566-70. PubMed ID: 2543131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of simian immunodeficiency virus regulatory genes.
    Colombini S; Arya SK; Reitz MS; Jagodzinski L; Beaver B; Wong-Staal F
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4813-7. PubMed ID: 2544874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.